drugset / Trial / NCT05111431

A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children

NCT05111431

Phase 3 Completed 159 enrolled Shanghai Hengrui Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the efficacy, and safety of dexmedetomidine hydrochloride nasal spray for preoperative sedation in children.

Timeline

Start
2021-11-24
Primary completion
2022-05-20
Completion
2022-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 30 ug Intranasal
Subject Dexmedetomidine Other / unclassified 50 ug Intranasal

Indications

No indication recorded.